Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 933 | 1065 | 960 | 1255 | 1816 |
Fund Return | 6.46% | -6.66% | 6.46% | -1.35% | 4.64% | 6.15% |
Place in category | 382 | 336 | 382 | 225 | 106 | 19 |
% in Category | 50 | 39 | 50 | 42 | 18 | 3 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Growth Fund Amer A | 155.72B | 28.43 | 6.87 | 13.67 | ||
American Funds American Balanced A | 111.66B | 14.95 | 4.82 | 8.14 | ||
American Funds Invmt Co of Amer A | 94.95B | 24.95 | 10.70 | 11.82 | ||
American Funds Washington Mutual A | 89.08B | 19.01 | 8.49 | 11.36 | ||
VA CollegeAmerica 529 AMCAP 529A | 85.7B | 21.11 | 4.12 | 10.86 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DFA Emerging Markets Core Equity I | 26.69B | 7.32 | 1.18 | 4.84 | ||
Fidelity Series Emerging Markets | 21.52B | 7.84 | -2.15 | 5.01 | ||
US00771X4198 | 20.32B | 6.20 | 2.67 | - | ||
American Funds New World R6 | 20.15B | 6.88 | -0.94 | 6.57 | ||
American Funds New World F2 | 17.65B | 6.79 | -1.05 | 6.46 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Taiwan Semicon | TW0002330008 | 3.56 | 1,120.00 | +1.36% | |
Tencent Holdings | KYG875721634 | 2.47 | 379.80 | -0.68% | |
Microsoft | US5949181045 | 2.34 | 429.03 | +1.05% | |
MercadoLibre | US58733R1023 | 1.91 | 1,836.00 | -0.06% | |
Novo Nordisk B | DK0062498333 | 1.79 | 575.6 | -4.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review